(D-PHE12,NLE21·38,Α-ME-LEU37)-CRF (12-41) (HUMAN, RAT)
| 中文名稱 | (D-PHE12,NLE21·38,Α-ME-LEU37)-CRF (12-41) (HUMAN, RAT) |
|---|---|
| 中文同義詞 | (D-PHE12,NLE21·38,Α-ME-LEU37)-CRF (12-41) (HUMAN, RAT) |
| 英文名稱 | (D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat) |
| 英文同義詞 | (D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat);12-41-Corticotropin-releasing factor (human), 12-D-phenylalanine-21-L-norleucine-37-(2-methyl-L-leucine)-38-L-norleucine- (9CI);12-41-Corticotropin-releasing factor(human),12-D-phenylalanine-21-L-norleucine-37-(2-methyl-L-leucine)-38-L-norleucine-;(D-PHE12,NLE21·38,Α-ME-LEU37)-CRF(12-41)(HUMAN,RAT);(D-Phe12,Nle21·3?,α-Me-Leu3?)-CRF (12-41) (human, rat) trifluoroacetate salt;(D-Phe??,Nle??·??,α-Me-Leu??)-CRF (12-41) (human, rat) trifluoroacetate salt;D-Phe??,Nle??·??,α-Me-Leu??)-CRF (12-41) (human, rat);H-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-A la-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-a-Me-Leu-Nle-Glu-Ile-Ile-NH 2 trifluoroacetate salt |
| CAS號 | 150646-45-0 |
| 分子式 | C159H267N49O43 |
| 分子量 | 3553.13 |
| EINECS號 | |
| 相關類別 | 標準品 |
| Mol文件 | 150646-45-0.mol |
| 結構式 |  |
(D-PHE12,NLE21·38,Α-ME-LEU37)-CRF (12-41) (HUMAN, RAT) 性質
| 密度 | 1.43±0.1 g/cm3(Predicted) |
|---|---|
| 序列 | {d-Phe}-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-{Nle}-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-{Leu(α-Me)}-{Nle}-Glu-Ile-Ile-NH2 |
(D-Phe12,Nle21,38,α-Me-Leu37)-CRF (12-41) (human, rat) 是一種 CRF 拮抗劑。(D-Phe12,Nle21,38,α-Me-Leu37)-CRF (12-41) (human, rat) 阻止 IL-1a 誘導的黃體生成素 (LH) 抑制。